Team:Washington/DataTable

From 2010.igem.org

(Difference between revisions)
 
(4 intermediate revisions not shown)
Line 1: Line 1:
 +
__NOTOC__
 +
{{Template:Team:Washington/Templates/Header}}
 +
<html>
 +
<script type="text/javascript">
 +
$(function() {
 +
  var mainimg = document.getElementById("mainimg");
 +
  var default_src = mainimg.src;
 +
  var restore_mainimg = function() {
 +
    mainimg.src = default_src;
 +
  };
 +
  $(document.getElementById("area_target")).hover(function() {
 +
    mainimg.src = "/wiki/images/1/1d/Main_graphic2_target.png";
 +
  }, restore_mainimg);
 +
  $(document.getElementById("area_secretion")).hover(function() {
 +
    mainimg.src = "/wiki/images/2/23/Main_graphic2_secretion.png";
 +
  }, restore_mainimg);
 +
  $(document.getElementById("area_display")).hover(function() {
 +
    mainimg.src = "/wiki/images/a/aa/Main_graphic2_display.png";
 +
  }, restore_mainimg);
 +
  $(document.getElementById("area_release")).hover(function() {
 +
    mainimg.src = "/wiki/images/e/ed/Main_graphic2_release.png";
 +
  }, restore_mainimg);
 +
});
 +
</script>
 +
</html>
 +
<!---------------------------------------PAGE CONTENT GOES BELOW THIS---------------------------------------->
 +
 +
<html xmlns:v="urn:schemas-microsoft-com:vml"
<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:o="urn:schemas-microsoft-com:office:office"
Line 21: Line 49:
{mso-displayed-decimal-separator:"\.";
{mso-displayed-decimal-separator:"\.";
mso-displayed-thousand-separator:"\,";}
mso-displayed-thousand-separator:"\,";}
-
.font013667
 
-
{color:black;
 
-
font-size:11.0pt;
 
-
font-weight:400;
 
-
font-style:normal;
 
-
text-decoration:none;
 
-
font-family:Calibri, sans-serif;
 
-
mso-font-charset:0;}
 
.font513667
.font513667
{color:black;
{color:black;
Line 36: Line 56:
text-decoration:none;
text-decoration:none;
font-family:Tahoma, sans-serif;
font-family:Tahoma, sans-serif;
-
mso-font-charset:0;}
 
-
.font613667
 
-
{color:black;
 
-
font-size:11.0pt;
 
-
font-weight:400;
 
-
font-style:italic;
 
-
text-decoration:none;
 
-
font-family:Calibri, sans-serif;
 
mso-font-charset:0;}
mso-font-charset:0;}
.xl6413667
.xl6413667
Line 180: Line 192:
font-style:normal'>Mutant Data Table</h1>
font-style:normal'>Mutant Data Table</h1>
-
<table border=0 cellpadding=0 cellspacing=0 width=1021 class=xl6413667
+
<table border=0 cellpadding=0 cellspacing=0 width=805 class=xl6413667
-
  style='border-collapse:collapse;table-layout:fixed;width:766pt'>
+
  style='border-collapse:collapse;table-layout:fixed;width:604pt'>
  <col class=xl6413667 width=172 style='mso-width-source:userset;mso-width-alt:
  <col class=xl6413667 width=172 style='mso-width-source:userset;mso-width-alt:
  6290;width:129pt'>
  6290;width:129pt'>
-
<col class=xl6413667 width=216 style='mso-width-source:userset;mso-width-alt:
 
-
7899;width:162pt'>
 
  <col class=xl6413667 width=297 style='mso-width-source:userset;mso-width-alt:
  <col class=xl6413667 width=297 style='mso-width-source:userset;mso-width-alt:
  10861;width:223pt'>
  10861;width:223pt'>
Line 193: Line 203:
   <td height=26 class=xl7013667 width=172 style='height:20.1pt;width:129pt'>Mutant
   <td height=26 class=xl7013667 width=172 style='height:20.1pt;width:129pt'>Mutant
   Name</td>
   Name</td>
-
  <td class=xl7013667 width=216 style='width:162pt'>Brief Description</td>
 
   <td class=xl7013667 width=297 style='width:223pt'>Features and Mutations</td>
   <td class=xl7013667 width=297 style='width:223pt'>Features and Mutations</td>
   <td class=xl6613667 width=168 style='width:126pt'>Transpeptidation per DCP</td>
   <td class=xl6613667 width=168 style='width:126pt'>Transpeptidation per DCP</td>
Line 200: Line 209:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>CapD</td>
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>CapD</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A protein native to <font
 
-
  class="font613667">Bacillus anthracis </font><font class="font013667">which
 
-
  cleaves poly-D-&#947;-glutamate (PDGA) and anchors it to the bacterium's
 
-
  peptidoglycan</font></td>
 
   <td class=xl6513667 width=297 style='width:223pt'>No Signal Sequence, Triple
   <td class=xl6513667 width=297 style='width:223pt'>No Signal Sequence, Triple
   band on protein agarose gel</td>
   band on protein agarose gel</td>
Line 211: Line 216:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>CapD_CP</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>CapD_CP</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A circularly permuted CapD
 
-
  with a Foldit-designed linker</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Foldit created linker,
   <td class=xl6513667 width=297 style='width:223pt'>Foldit created linker,
   Circular Permutation, No Signal Sequence, Single band on protein agarose gel</td>
   Circular Permutation, No Signal Sequence, Single band on protein agarose gel</td>
Line 220: Line 223:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>CapD_CPNFDelta</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>CapD_CPNFDelta</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A circularly permuted CapD
 
-
  with deletion of floppy areas</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Foldit created linker,
   <td class=xl6513667 width=297 style='width:223pt'>Foldit created linker,
   Circular Permutation, No Signal Sequence, Single band on protein agarose gel,
   Circular Permutation, No Signal Sequence, Single band on protein agarose gel,
Line 230: Line 231:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24A</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24A</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   24 on CapDCP from Phenylalanine to Alanine, Foldit-created linker, Circular
   24 on CapDCP from Phenylalanine to Alanine, Foldit-created linker, Circular
Line 241: Line 239:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H</td>
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   24 on CapDCP from Phenylalanine to Histidine, Foldit-created linker, Circular
   24 on CapDCP from Phenylalanine to Histidine, Foldit-created linker, Circular
Line 253: Line 248:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H,
   L40R, T59D_M61S</td>
   L40R, T59D_M61S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine
   24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine
Line 267: Line 259:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H,
   L40R, T59N_M61S</td>
   L40R, T59N_M61S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine
   24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine
Line 281: Line 270:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H,
   L40R, T59S_M61S</td>
   L40R, T59S_M61S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   24, 40, 59, and 61 on CapDCP from Phenylalanine to Histidine, Leucine to
   24, 40, 59, and 61 on CapDCP from Phenylalanine to Histidine, Leucine to
Line 295: Line 281:
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24H,
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24H,
   R356K</td>
   R356K</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   24 and 356 on CapDCP from Phenylalanine to Histidine and Arginine to Lysine,
   24 and 356 on CapDCP from Phenylalanine to Histidine and Arginine to Lysine,
Line 308: Line 291:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H,
   T59R</td>
   T59R</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   24 and 59 on CapDCPfrom Phenylalanine to Histidine and Threonine to Arginine,
   24 and 59 on CapDCPfrom Phenylalanine to Histidine and Threonine to Arginine,
Line 320: Line 300:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24H,T59N</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24H,T59N</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   24 and 59 on CapDCP from Phenylalanine to Histidine and Threonine to
   24 and 59 on CapDCP from Phenylalanine to Histidine and Threonine to
Line 332: Line 309:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24W</td>
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24W</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   24 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker,
   24 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker,
Line 343: Line 317:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   24 on CapDCP from Phenylalanine to Tyrosine. Foldit-created linker, Circular
   24 on CapDCP from Phenylalanine to Tyrosine. Foldit-created linker, Circular
Line 355: Line 326:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24Y,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24Y,
   L40R</td>
   L40R</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   24 and 40 on CapDCP from Phenylalanine to Tyrosine and Leucine to Arginine,
   24 and 40 on CapDCP from Phenylalanine to Tyrosine and Leucine to Arginine,
Line 368: Line 336:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24Y,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24Y,
   L40R, T59N</td>
   L40R, T59N</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   24, 40, 59 on CapDCP from Phenylalanine to Tyrosine, Leucine to
   24, 40, 59 on CapDCP from Phenylalanine to Tyrosine, Leucine to
Line 381: Line 346:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,R305K</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,R305K</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   24 and 305 on CapDCP from Phenylalanine to Tyrosine and Arginine to Lysine,
   24 and 305 on CapDCP from Phenylalanine to Tyrosine and Arginine to Lysine,
Line 393: Line 355:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,T59N</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,T59N</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   24 and 59 on CapDCP from Phenylalanine to Tyrosine and Threonine to
   24 and 59 on CapDCP from Phenylalanine to Tyrosine and Threonine to
Line 405: Line 364:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,T59N,R305K</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,T59N,R305K</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   24, 59, and 356 on CapDCP from Phenylalanine to Tyrosine, Threonine to
   24, 59, and 356 on CapDCP from Phenylalanine to Tyrosine, Threonine to
Line 417: Line 373:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F60W</td>
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F60W</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   60 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker,
   60 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker,
Line 428: Line 381:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>G79A</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>G79A</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   79 on CapDCP from Glycine to Alanine. Foldit-created linker, Circular
   79 on CapDCP from Glycine to Alanine. Foldit-created linker, Circular
Line 439: Line 389:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>I83T</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>I83T</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   83 on CapDCP from Isoleucine to Threonine. Foldit-created linker, Circular
   83 on CapDCP from Isoleucine to Threonine. Foldit-created linker, Circular
Line 450: Line 397:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>I83V</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>I83V</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   83 on CapDCP from Isoleucine to Valine. Foldit-created linker, Circular
   83 on CapDCP from Isoleucine to Valine. Foldit-created linker, Circular
Line 461: Line 405:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40A</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40A</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   40 on CapDCP from Leucine to Alanine. Foldit-created linker, Circular
   40 on CapDCP from Leucine to Alanine. Foldit-created linker, Circular
Line 472: Line 413:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40R</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40R</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   40 on CapDCP from Leucine to Arginine. Foldit-created linker, Circular
   40 on CapDCP from Leucine to Arginine. Foldit-created linker, Circular
Line 483: Line 421:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40S</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   40 on CapDCP from Leucine to Serine. Foldit-created linker, Circular
   40 on CapDCP from Leucine to Serine. Foldit-created linker, Circular
Line 494: Line 429:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40W</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40W</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   40 on CapDCP from Leucine to Tryptophan. Foldit-created linker, Circular
   40 on CapDCP from Leucine to Tryptophan. Foldit-created linker, Circular
Line 505: Line 437:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61H</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61H</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   61 on CapDCP from Methionine to Histidine. Foldit-created linker, Circular
   61 on CapDCP from Methionine to Histidine. Foldit-created linker, Circular
Line 516: Line 445:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61N</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61N</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   61 on CapDCP from Methionine to Asparagine. Foldit-created linker, Circular
   61 on CapDCP from Methionine to Asparagine. Foldit-created linker, Circular
Line 527: Line 453:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61S</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   61 on CapDCP from Methionine to Serine. Foldit-created linker, Circular
   61 on CapDCP from Methionine to Serine. Foldit-created linker, Circular
Line 538: Line 461:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>N23K</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>N23K</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   23 on CapDCP from Asparagine to Lysine. Foldit-created linker, Circular
   23 on CapDCP from Asparagine to Lysine. Foldit-created linker, Circular
Line 549: Line 469:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>N23Q</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>N23Q</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   23 on CapDCP from Asparagine to Glutamine. Foldit-created linker, Circular
   23 on CapDCP from Asparagine to Glutamine. Foldit-created linker, Circular
Line 560: Line 477:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S143K</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S143K</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   143 on CapDCP from Serine to Lysine. Foldit-created linker, Circular
   143 on CapDCP from Serine to Lysine. Foldit-created linker, Circular
Line 572: Line 486:
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S22I,
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S22I,
   T59A</td>
   T59A</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   22 and 59 on CapDCP from Serine to Isoleucine and Threonine to Alanine,
   22 and 59 on CapDCP from Serine to Isoleucine and Threonine to Alanine,
Line 585: Line 496:
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S22Q,
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S22Q,
   T59Q</td>
   T59Q</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   22 and 59 on CapDCP from Serine to Glutamine and Threonine to Glutamine,
   22 and 59 on CapDCP from Serine to Glutamine and Threonine to Glutamine,
Line 598: Line 506:
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S57H,
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S57H,
   M61H</td>
   M61H</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   57 and 61 on CapDCP from Serine to Histidine and Methionine to Histidine,
   57 and 61 on CapDCP from Serine to Histidine and Methionine to Histidine,
Line 611: Line 516:
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T18L,
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T18L,
   T59Q, M61N, F452W</td>
   T59Q, M61N, F452W</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   18, 59, 61, and 452 on CapDCP from Threonine to Leucine, Threonine to
   18, 59, 61, and 452 on CapDCP from Threonine to Leucine, Threonine to
Line 624: Line 526:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T18S_T20S</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T18S_T20S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   18 and 20 on CapDCP from Threonine to Serine and Threonine to Serine,<span
   18 and 20 on CapDCP from Threonine to Serine and Threonine to Serine,<span
Line 636: Line 535:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20A</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20A</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   20 on CapDCP from Threonine to Alanine. Foldit-created linker, Circular
   20 on CapDCP from Threonine to Alanine. Foldit-created linker, Circular
Line 647: Line 543:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20C</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20C</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   20 on CapDCP from Threonine to Cystine. Foldit-created linker, Circular
   20 on CapDCP from Threonine to Cystine. Foldit-created linker, Circular
Line 658: Line 551:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   20 on CapDCP from Threonine to Serine. Foldit-created linker, Circular
   20 on CapDCP from Threonine to Serine. Foldit-created linker, Circular
Line 670: Line 560:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40D</td>
   L40D</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Asparagine,
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Asparagine,
Line 683: Line 570:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40E</td>
   L40E</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamic Acid,
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamic Acid,
Line 696: Line 580:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40F</td>
   L40F</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Phenylalanine,
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Phenylalanine,
Line 709: Line 590:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40H</td>
   L40H</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Histidine,
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Histidine,
Line 722: Line 600:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40K</td>
   L40K</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Lysine,
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Lysine,
Line 735: Line 610:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40Q</td>
   L40Q</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamine,
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamine,
Line 748: Line 620:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40R</td>
   L40R</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Arginine,
   20 and 40 on CapDCP from Threonine to Serine and Leucine to Arginine,
Line 761: Line 630:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40R, F60E</td>
   L40R, F60E</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and
   20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and
Line 774: Line 640:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40R, F60Q</td>
   L40R, F60Q</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and
   20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and
Line 787: Line 650:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40R, N81E</td>
   L40R, N81E</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and
   20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and
Line 800: Line 660:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40R, N81Q</td>
   L40R, N81Q</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20, 40, and 81 on CapDCP from Threonine to Serine, Leucine to Arginine, and
   20, 40, and 81 on CapDCP from Threonine to Serine, Leucine to Arginine, and
Line 813: Line 670:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40R, T59K</td>
   L40R, T59K</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20, 40, and 59 on CapDCP from Threonine to Serine, Leucine to Arginine, and
   20, 40, and 59 on CapDCP from Threonine to Serine, Leucine to Arginine, and
Line 826: Line 680:
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S,
   L40R, T59K_M61S</td>
   L40R, T59K_M61S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20, 40, 59, and 61 on CapDCP from Threonine to Serine, Leucine to Arginine,
   20, 40, 59, and 61 on CapDCP from Threonine to Serine, Leucine to Arginine,
Line 840: Line 691:
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,
   T59Q, M61T</td>
   T59Q, M61T</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Glutamine,
   20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Glutamine,
Line 852: Line 700:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61A</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61A</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Alanine,
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Alanine,
Line 864: Line 709:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61C</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61C</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Cystine,
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Cystine,
Line 876: Line 718:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61D</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61D</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Aspartic Acid,
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Aspartic Acid,
Line 888: Line 727:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61G</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61G</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Glycine,
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Glycine,
Line 900: Line 736:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61L</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61L</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Leucine,
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Leucine,
Line 912: Line 745:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61N</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61N</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Asparagine,
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Asparagine,
Line 924: Line 754:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61S</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Serine,
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Serine,
Line 936: Line 763:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61T</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61T</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Threonine,
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Threonine,
Line 948: Line 772:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61V</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61V</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Valine,
   20 and 61 on CapDCP from Threonine to Serine and Methionine to Valine,
Line 960: Line 781:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,T59N</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,T59N</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 59 on CapDCP from Threonine to Serine and Threonine to Asparagine,
   20 and 59 on CapDCP from Threonine to Serine and Threonine to Asparagine,
Line 972: Line 790:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,T59S_M61S</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,T59S_M61S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Serine, and
   20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Serine, and
Line 984: Line 799:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24H</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24H</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Histidine,
   20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Histidine,
Line 996: Line 808:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24Y</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24Y</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Tyrosine,
   20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Tyrosine,
Line 1,008: Line 817:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24Y,T59N</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24Y,T59N</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   20, 24, and 59 on CapDCP from Threonine to Serine, Phenylalanine to Tyrosine,
   20, 24, and 59 on CapDCP from Threonine to Serine, Phenylalanine to Tyrosine,
Line 1,020: Line 826:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2A</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2A</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2
   on CapDCP from Threonine to Alanine. Foldit-created linker, Circular
   on CapDCP from Threonine to Alanine. Foldit-created linker, Circular
Line 1,031: Line 834:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2C</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2C</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at destroying all activity with poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2
   on CapDCP from Threonine to Cystine. Foldit-created linker, Circular
   on CapDCP from Threonine to Cystine. Foldit-created linker, Circular
Line 1,041: Line 842:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2
   on CapDCP from Threonine to Serine. Foldit-created linker, Circular
   on CapDCP from Threonine to Serine. Foldit-created linker, Circular
Line 1,052: Line 850:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T18S_T20S</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T18S_T20S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   2, 18, and 20 on CapDCP from Threonine to Serine, Threonine to Serine, and
   2, 18, and 20 on CapDCP from Threonine to Serine, Threonine to Serine, and
Line 1,064: Line 859:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T18S_T20S,T59S_M61S</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T18S_T20S,T59S_M61S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   2, 18, 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to
   2, 18, 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to
Line 1,077: Line 869:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T20S</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T20S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   2 and 20 on CapDCP from Threonine to Serine and Threonine to Serine,
   2 and 20 on CapDCP from Threonine to Serine and Threonine to Serine,
Line 1,089: Line 878:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2V</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2V</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at destroying all activity with poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2
   on CapDCP from Threonine to Valine. Foldit-created linker, Circular
   on CapDCP from Threonine to Valine. Foldit-created linker, Circular
Line 1,099: Line 886:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59H_M61A</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59H_M61A</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   59 and 61 on CapDCP from Threonine to Histidine and Methionine to Alanine,
   59 and 61 on CapDCP from Threonine to Histidine and Methionine to Alanine,
Line 1,111: Line 895:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59H_M61T</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59H_M61T</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   59 and 61 on CapDCP from Threonine to Histidine and Methionine to Threonine,
   59 and 61 on CapDCP from Threonine to Histidine and Methionine to Threonine,
Line 1,123: Line 904:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59M</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59M</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   59 on CapDCP from Threonine to Methionine. Foldit-created linker, Circular
   59 on CapDCP from Threonine to Methionine. Foldit-created linker, Circular
Line 1,134: Line 912:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59N</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59N</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   59 on CapDCP from Threonine to Asparagine. Foldit-created linker, Circular
   59 on CapDCP from Threonine to Asparagine. Foldit-created linker, Circular
Line 1,145: Line 920:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59Q</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59Q</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   59 on CapDCP from Threonine to Glutamine. Foldit-created linker, Circular
   59 on CapDCP from Threonine to Glutamine. Foldit-created linker, Circular
Line 1,157: Line 929:
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59Q,
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59Q,
   M61Q, F452W</td>
   M61Q, F452W</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   59, 61, and 452 on CapDCP from Threonine to Glutamine, Threonine to
   59, 61, and 452 on CapDCP from Threonine to Glutamine, Threonine to
Line 1,170: Line 939:
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
  <tr height=93 style='mso-height-source:userset;height:69.95pt'>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59S</td>
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59S</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue
   59 on CapDCP from Threonine to Serine. Foldit-created linker, Circular
   59 on CapDCP from Threonine to Serine. Foldit-created linker, Circular
Line 1,182: Line 948:
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59S,
   <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59S,
   M61H</td>
   M61H</td>
-
  <td class=xl6513667 width=216 style='width:162pt'>A mutated CapDCP protein
 
-
  aimed at increasing hydrolysis and decreasing transpeptidation of
 
-
  poly-D-gamma-glutamate.</td>
 
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues
   59 and 61 on CapDCP from Threonine to Serine and Methionine to Histidine,
   59 and 61 on CapDCP from Threonine to Serine and Methionine to Histidine,
Line 1,195: Line 958:
  <tr height=0 style='display:none'>
  <tr height=0 style='display:none'>
   <td width=172 style='width:129pt'></td>
   <td width=172 style='width:129pt'></td>
-
  <td width=216 style='width:162pt'></td>
 
   <td width=297 style='width:223pt'></td>
   <td width=297 style='width:223pt'></td>
   <td width=168 style='width:126pt'></td>
   <td width=168 style='width:126pt'></td>
Line 1,212: Line 974:
</html>
</html>
 +
<!---------------------------------------PAGE CONTENT GOES ABOVE THIS---------------------------------------->
 +
 +
<div style="text-align:center">
 +
'''&larr; [[Team:Washington/Gram_Positive/Test|Back to Testing the Gram(+) Therapeutic]]'''
 +
&nbsp; &nbsp; &nbsp;
 +
</div>

Latest revision as of 20:37, 25 October 2010


Mutant Data Table

Mutant Data Table

Mutant Name Features and Mutations Transpeptidation per DCP Hydrolysis per DCP
CapD No Signal Sequence, Triple band on protein agarose gel 0.491 0.713
CapD_CP Foldit created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 1.000 1.000
CapD_CPNFDelta Foldit created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel, Removed "floppy" section to compact protein 1.035 0.878
F24A Point mutation at residue 24 on CapDCP from Phenylalanine to Alanine, Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.021 0.061
F24H Point mutation at residue 24 on CapDCP from Phenylalanine to Histidine, Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.108 1.205
F24H, L40R, T59D_M61S Point mutation at residues 24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine to Arginine, Threonine to Asparagine, and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.001 0.006
F24H, L40R, T59N_M61S Point mutation at residues 24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine to Arginine, Threonine to Aspartic Acid, and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.058 1.050
F24H, L40R, T59S_M61S Point mutation at residues 24, 40, 59, and 61 on CapDCP from Phenylalanine to Histidine, Leucine to Arginine, Threonine to Serine, and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.000 0.007
F24H, R356K Point mutation at residues 24 and 356 on CapDCP from Phenylalanine to Histidine and Arginine to Lysine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.129 0.257
F24H, T59R Point mutation at residues 24 and 59 on CapDCPfrom Phenylalanine to Histidine and Threonine to Arginine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.011 0.005
F24H,T59N Point mutation at residues 24 and 59 on CapDCP from Phenylalanine to Histidine and Threonine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.007 0.029
F24W Point mutation at residue 24 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.006 0.044
F24Y Point mutation at residue 24 on CapDCP from Phenylalanine to Tyrosine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.593 0.887
F24Y, L40R Point mutation at residues 24 and 40 on CapDCP from Phenylalanine to Tyrosine and Leucine to Arginine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.009 -0.013
F24Y, L40R, T59N Point mutation at residues 24, 40, 59 on CapDCP from Phenylalanine to Tyrosine, Leucine to Arginine,  and Threonine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.003 0.157
F24Y,R305K Point mutation at residues 24 and 305 on CapDCP from Phenylalanine to Tyrosine and Arginine to Lysine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.002 0.233
F24Y,T59N Point mutation at residues 24 and 59 on CapDCP from Phenylalanine to Tyrosine and Threonine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.008 0.165
F24Y,T59N,R305K Point mutation at residues 24, 59, and 356 on CapDCP from Phenylalanine to Tyrosine, Threonine to Asparagine, and Arginine to Lysine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.002 0.127
F60W Point mutation at residue 60 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.239 0.489
G79A Point mutation at residue 79 on CapDCP from Glycine to Alanine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.040 -0.511
I83T Point mutation at residue 83 on CapDCP from Isoleucine to Threonine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.009 0.006
I83V Point mutation at residue 83 on CapDCP from Isoleucine to Valine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.003 0.043
L40A Point mutation at residue 40 on CapDCP from Leucine to Alanine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.150 0.413
L40R Point mutation at residue 40 on CapDCP from Leucine to Arginine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 1.157 1.527
L40S Point mutation at residue 40 on CapDCP from Leucine to Serine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.166 0.577
L40W Point mutation at residue 40 on CapDCP from Leucine to Tryptophan. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.825 1.215
M61H Point mutation at residue 61 on CapDCP from Methionine to Histidine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel -0.003 0.002
M61N Point mutation at residue 61 on CapDCP from Methionine to Asparagine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.011 0.002
M61S Point mutation at residue 61 on CapDCP from Methionine to Serine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.262 0.485
N23K Point mutation at residue 23 on CapDCP from Asparagine to Lysine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.818 0.839
N23Q Point mutation at residue 23 on CapDCP from Asparagine to Glutamine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.165 0.646
S143K Point mutation at residue 143 on CapDCP from Serine to Lysine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.574 0.426
S22I, T59A Point mutation at residues 22 and 59 on CapDCP from Serine to Isoleucine and Threonine to Alanine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.030 -0.057
S22Q, T59Q Point mutation at residues 22 and 59 on CapDCP from Serine to Glutamine and Threonine to Glutamine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel -0.012 0.085
S57H, M61H Point mutation at residues 57 and 61 on CapDCP from Serine to Histidine and Methionine to Histidine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel -0.004 -0.007
T18L, T59Q, M61N, F452W Point mutation at residues 18, 59, 61, and 452 on CapDCP from Threonine to Leucine, Threonine to Glutamine, Methionine to Asparagine, and Phenylalanine to Tryptophan,  respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.020 -0.028
T18S_T20S Point mutation at residues 18 and 20 on CapDCP from Threonine to Serine and Threonine to Serine,  respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.617 1.186
T20A Point mutation at residue 20 on CapDCP from Threonine to Alanine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.011 0.021
T20C Point mutation at residue 20 on CapDCP from Threonine to Cystine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.090 0.142
T20S Point mutation at residue 20 on CapDCP from Threonine to Serine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.639 1.443
T20S, L40D Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.853 0.001
T20S, L40E Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamic Acid, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.163 0.637
T20S, L40F Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Phenylalanine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.246 0.335
T20S, L40H Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Histidine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.001 0.012
T20S, L40K Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Lysine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.000 0.007
T20S, L40Q Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.126 0.478
T20S, L40R Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Arginine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.000 0.009
T20S, L40R, F60E Point mutation at residues 20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and Phenylalanine to Glutamic Acid, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.048 0.028
T20S, L40R, F60Q Point mutation at residues 20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and Phenylalanine to Glutamine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.002 0.007
T20S, L40R, N81E Point mutation at residues 20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and Phenylalanine to Glutamine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.001 -0.004
T20S, L40R, N81Q Point mutation at residues 20, 40, and 81 on CapDCP from Threonine to Serine, Leucine to Arginine, and Asparagine to Glutamine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.422 0.321
T20S, L40R, T59K Point mutation at residues 20, 40, and 59 on CapDCP from Threonine to Serine, Leucine to Arginine, and Threonine to Lysine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.048 0.033
T20S, L40R, T59K_M61S Point mutation at residues 20, 40, 59, and 61 on CapDCP from Threonine to Serine, Leucine to Arginine, Threonine to Lysine, and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.010 0.032
T20S, T59Q, M61T Point mutation at residues 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Glutamine, and Methionine to Threonine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.007 -0.069
T20S,M61A Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Alanine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.005 0.045
T20S,M61C Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Cystine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.102 0.207
T20S,M61D Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Aspartic Acid, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.004 0.003
T20S,M61G Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Glycine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.004 0.029
T20S,M61L Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Leucine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.004 0.029
T20S,M61N Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.003 0.002
T20S,M61S Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.007 0.053
T20S,M61T Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Threonine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.038 0.363
T20S,M61V Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Valine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.004 0.039
T20S,T59N Point mutation at residues 20 and 59 on CapDCP from Threonine to Serine and Threonine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.019 0.125
T20S,T59S_M61S Point mutation at residues 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Serine, and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.300 0.719
T20S_F24H Point mutation at residues 20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Histidine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.008 0.097
T20S_F24Y Point mutation at residues 20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Tyrosine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.040 0.201
T20S_F24Y,T59N Point mutation at residues 20, 24, and 59 on CapDCP from Threonine to Serine, Phenylalanine to Tyrosine, and Threonine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.013 0.048
T2A Point mutation at residue 2 on CapDCP from Threonine to Alanine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.007 -0.020
T2C Point mutation at residue 2 on CapDCP from Threonine to Cystine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.001 -0.005
T2S Point mutation at residue 2 on CapDCP from Threonine to Serine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.024 0.325
T2S,T18S_T20S Point mutation at residues 2, 18, and 20 on CapDCP from Threonine to Serine, Threonine to Serine, and Threonine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.144 0.250
T2S,T18S_T20S,T59S_M61S Point mutation at residues 2, 18, 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Serine, Threonine to Serine, Threonine to Serine and Threonine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.003 0.022
T2S,T20S Point mutation at residues 2 and 20 on CapDCP from Threonine to Serine and Threonine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.106 0.089
T2V Point mutation at residue 2 on CapDCP from Threonine to Valine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.000 0.000
T59H_M61A Point mutation at residues 59 and 61 on CapDCP from Threonine to Histidine and Methionine to Alanine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.000 0.000
T59H_M61T Point mutation at residues 59 and 61 on CapDCP from Threonine to Histidine and Methionine to Threonine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.000 0.000
T59M Point mutation at residue 59 on CapDCP from Threonine to Methionine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.008 0.008
T59N Point mutation at residue 59 on CapDCP from Threonine to Asparagine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.232 0.868
T59Q Point mutation at residue 59 on CapDCP from Threonine to Glutamine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.000 0.000
T59Q, M61Q, F452W Point mutation at residues 59, 61, and 452 on CapDCP from Threonine to Glutamine, Threonine to Glutamine, and Phenylalanine to Tryptophan, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel -0.014 0.037
T59S Point mutation at residue 59 on CapDCP from Threonine to Serine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 3.525 1.047
T59S, M61H Point mutation at residues 59 and 61 on CapDCP from Threonine to Serine and Methionine to Histidine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel 0.013 0.051

Back to Testing the Gram(+) Therapeutic